Skip to main content
Caplight Logo









Affirma Biotech

Affirma Biotech

Private
BarcelonaHealthcare & Life Scienceshttps://www.affirmabio.com/

Last Round

VC Round

Feb 1, 2024

Total Funding Raised

$1.31M

Company Overview

Affirma Biotech is a biotechnology company that develops orally available immunotherapeutic drugs for the treatment of severe infections and cancer.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

immunotherapysmall molecule discoverydrug discoverypreclinical biotechimmuno-oncologyI-OPD-L1 inhibitorsinfectious diseaseorally available drugsantiviral drugschronic hepatitis Bsevere influenzabroad-spectrum anti-infectivesdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Affirma Biotech Comparables

Compare Affirma Biotech with similar companies based on industry and business-model similarity.

Affirma Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aligos Therapeutics
74%
Olgram
74%
Arbutus Biopharma Corp
74%

Affirma Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 1, 2024
GrantNov 21, 2023
SeedSep 19, 2022
Pre SeedDec 10, 2021

Key People

Founding team and executive leadership

Maribel Berges

CEO & President of the Board

Executive Team

Affirma Biotech Investors

Notable investors and investment history

Affirma Biotech investors
InvestorRounds
Nara CapitalVC Round
SeedBlinkVC Round
Center for Technological Development and InnovationGrant
Capital CellVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 81% MoM.

  • May 1, 2025

    Monthly visitors grew 71% MoM, from 762 to 1.3K.

Affirma Biotech Filings

Explore SEC and related filing metadata, where available.

Affirma Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Affirma Biotech's valuation, stock price, and market status.

Is Affirma Biotech a public or private company?

Affirma Biotech is a private company.

What is the current stock price of Affirma Biotech?

Affirma Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Affirma Biotech worth (valuation)?

Valuation information for Affirma Biotech is not publicly available.

Can I buy Affirma Biotech stock?

Affirma Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Affirma Biotech's last funding round?

Funding round information for Affirma Biotech is not publicly available.

Who are the main investors in Affirma Biotech?

Investor information for Affirma Biotech is not publicly disclosed.

Will Affirma Biotech IPO soon?

No public IPO plans have been announced for Affirma Biotech.

How can I track Affirma Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Affirma Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBarcelona
Employee Range5
Year Founded2020
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?